Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -128.38%-331.75M | 1,158.87%1.17B | 131.34%92.87M | 85.26%-296.3M | -257.68%-2.01B | 523.17%1.27B | -79.12%204.6M | 10.66%979.68M | -21.44%885.34M | 39.60%1.13B |
Net profit before non-cash adjustment | -142.02%-891.01M | 65.40%-368.16M | 57.58%-1.06B | -201.12%-2.51B | 645.22%2.48B | 126.50%332.88M | -356.48%-1.26B | -25.30%489.78M | -8.61%655.69M | -10.44%717.43M |
Total adjustment of non-cash items | -15.33%1.21B | 21.16%1.43B | -21.36%1.18B | 150.94%1.5B | -383.53%-2.94B | 9.50%1.04B | 55.26%947.26M | 209.60%610.12M | -62.73%197.07M | 252.62%528.76M |
-Depreciation and amortization | -2.64%1.26B | -3.83%1.29B | -31.12%1.34B | -36.64%1.95B | -1.20%3.07B | 106.54%3.11B | 304.55%1.51B | -14.19%372.03M | 24.87%433.54M | 8.10%347.2M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | 2,121.99%248.02M | -94.72%11.16M | --211.27M | ---- | ---- | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2,261.81%-209.8M | 110.80%9.71M |
-Disposal profit | -105.16%-2.5M | 343.35%48.35M | -207.31%-19.87M | 100.30%18.52M | -91.81%-6.07B | -30,217.95%-3.17B | 237.10%10.51M | 4.32%-7.67M | -75.16%-8.01M | 45.17%-4.57M |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 76.16%11.54M | --6.55M |
-Other non-cash items | -149.23%-44.2M | 162.94%89.77M | 69.43%-142.64M | -147.35%-466.57M | -117.42%-188.62M | 238.91%1.08B | -417.21%-779.58M | 913.88%245.76M | -117.77%-30.2M | 284.47%169.88M |
Changes in working capital | -690.12%-649.14M | 624.89%110M | -102.93%-20.96M | 146.07%714.12M | -1,529.63%-1.55B | -118.52%-95.13M | 527.14%513.54M | -469.00%-120.23M | 127.33%32.58M | 17.07%-119.22M |
-Change in receivables | -186.06%-420.09M | 266.05%488.14M | -1,116.12%-293.97M | 96.10%-24.17M | -262.54%-619.15M | 66.26%380.93M | 169.28%229.12M | -223.56%-330.72M | 333.66%267.66M | -297.02%-114.55M |
-Change in inventory | -53.00%-258.7M | -389.27%-169.08M | -93.86%58.45M | 229.65%952.36M | -19.07%-734.59M | -47,874.18%-616.95M | -100.89%-1.29M | 185.75%145.15M | -821.45%-169.27M | 116.46%23.46M |
-Change in payables | 119.26%39.46M | -189.95%-204.92M | 207.11%227.8M | -1.82%-212.69M | -271.02%-208.89M | -23.51%122.15M | 2,613.09%159.68M | 90.34%-6.35M | -133.94%-65.81M | 52.62%-28.13M |
-Provision for loans, leases and other losses | -136.69%-9.81M | 68.69%-4.15M | -862.06%-13.24M | -111.06%-1.38M | -33.65%12.44M | -85.12%18.75M | 75.75%126.02M | --71.7M | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 10.38%-62.56M | 3.98%-69.81M | -5.12%-72.7M | 37.61%-69.16M | 5.38%-110.85M | -19.57%-117.15M | -55.72%-97.98M | -121.82%-62.92M | 14.59%-28.37M | 9.35%-33.21M |
Interest received (cash flow from operating activities) | 0.36%4.77M | 60.37%4.76M | 14.30%2.97M | 3.10%2.59M | 3.20%2.52M | 2.61%2.44M | 8.10%2.38M | -22.77%2.2M | 5.52%2.85M | -71.02%2.7M |
Tax refund paid | 33.37%-71.49M | -111.04%-107.3M | 153.28%971.62M | -1,268.94%-1.82B | -28.02%-133.2M | 33.26%-104.05M | -128.12%-155.91M | 20.08%-68.34M | 43.30%-85.51M | 31.37%-150.81M |
Other operating cash inflow (outflow) | 38.95%111.01M | -61.00%79.89M | -39.79%204.84M | 61.24%340.22M | 134.44%211.01M | 169.97%90M | 50.67%33.34M | 796.92%22.13M | -70.41%2.47M | 706.29%8.34M |
Operating cash flow | -132.51%-350.02M | -10.25%1.08B | 164.98%1.2B | 9.54%-1.85B | -278.05%-2.04B | 8,546.81%1.15B | -101.55%-13.57M | 12.35%872.74M | -18.58%776.77M | 69.98%954M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -63.53%-544.13M | 47.18%-332.73M | -36.02%-629.97M | -104.89%-463.14M | 4,098.60%9.48B | 103.52%225.8M | -10.30%-6.41B | -1,264.56%-5.81B | 9.75%-425.94M | 44.73%-471.98M |
Net intangibles purchase and sale | 71.45%-925K | ---3.24M | --0 | ---- | 97.02%-200K | -511.00%-6.72M | 60.81%-1.1M | 83.59%-2.81M | -32.34%-17.11M | 51.72%-12.93M |
Net investment product transactions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.33M |
Net changes in other investments | -90.79%1.01M | -93.39%10.98M | 733.34%166.03M | 87.86%-26.22M | -23.74%-215.86M | -2,341.54%-174.45M | -106.80%-7.15M | -209.31%-3.46M | -270.27%-1.12M | 1,011.11%656K |
Investing cash flow | -67.40%-544.04M | 29.95%-324.99M | 5.19%-463.94M | -105.28%-489.36M | 20,657.01%9.26B | 100.70%44.63M | -10.33%-6.42B | -1,209.98%-5.82B | 8.53%-444.16M | -12.93%-485.58M |
Financing cash flow | ||||||||||
Net issuance payments of debt | 50.00%-10M | 95.52%-20M | -461.43%-446.04M | 98.83%-79.45M | -1,705.58%-6.78B | -137.37%-375.38M | -91.14%1B | 2,523.53%11.34B | -181.57%-468.02M | -10.50%-166.22M |
Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | -103.24%-108K | --3.34M | ---- | -4.51%200.53M |
Cash dividends paid | ---- | ---- | ---- | ---- | 49.50%-26.75M | -0.29%-52.97M | 0.09%-52.82M | 31.09%-52.86M | -159.81%-76.71M | 24.97%-29.52M |
Cash dividends for minorities | 0.00%-4.9M | 0.00%-4.9M | 0.00%-4.9M | 0.00%-4.9M | 0.00%-4.9M | 0.00%-4.9M | 0.00%-4.9M | 0.00%-4.9M | 0.00%-4.9M | 0.00%-4.9M |
Net other fund-raising expenses | 1.77%-1M | -1.80%-1.02M | -0.10%-1M | ---999K | ---- | --1K | ---- | ---- | 101.91%596K | -3,123,500.00%-31.24M |
Financing cash flow | 38.65%-15.9M | 94.27%-25.92M | -429.54%-451.94M | 98.75%-85.35M | -1,471.73%-6.81B | -145.76%-433.25M | -91.61%946.77M | 2,156.02%11.29B | -1,651.01%-549.03M | -304.57%-31.36M |
Net cash flow | ||||||||||
Beginning cash position | 40.56%2.52B | 18.84%1.79B | -61.65%1.51B | 11.79%3.93B | 27.50%3.51B | -66.57%2.75B | 334.08%8.24B | -10.23%1.9B | 26.05%2.11B | 9.57%1.68B |
Current changes in cash | -225.39%-909.97M | 155.78%725.7M | 111.72%283.71M | -684.62%-2.42B | -45.34%414.09M | 113.81%757.62M | -186.50%-5.49B | 3,030.61%6.34B | -149.52%-216.42M | 198.16%437.07M |
Cash adjustments other than cash changes | 0.00%-1K | ---1K | ---- | ---2K | ---- | ---- | -200.00%-1K | 200.00%1K | 0.00%-1K | -200.00%-1K |
End cash Position | -36.18%1.61B | 40.56%2.52B | 18.84%1.79B | -61.65%1.51B | 11.79%3.93B | 27.50%3.51B | -66.57%2.75B | 334.08%8.24B | -10.23%1.9B | 26.05%2.11B |
Free cash flow | -222.11%-901.05M | 54.46%737.88M | 120.63%477.73M | 16.65%-2.32B | -52.30%-2.78B | 71.64%-1.82B | -29.93%-6.43B | -1,626.74%-4.95B | -30.20%324.13M | 241.19%464.4M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |